basiliximab

Synonyms: CHI-621 | L04AC02 | SDZ-CHI-621 | Simulect®

basiliximab is an approved drug (FDA (1998), EMA (1998))

Compound class: Antibody

Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.

View more information in the IUPHAR Pharmacology Education Project: basiliximab

Immunopharmacology Comments
Basiliximab is an anti-IL-2 monoclonal used to prevent organ transplant rejection.

Immunopharmacology Comments

Basiliximab is an anti-IL-2 monoclonal used to prevent organ transplant rejection.

Immunopharmacology Disease
Disease	X-Refs	Comment	References
Allograft rejection		Used in combination with other anti-rejection drugs (cyclosporin A, corticosteroids, azathioprine and mycophenolate mofetil) to prevent renal allograft rejection.